Process View
Processing which a protein carries out itself. This involves actions such as the autolytic removal of residues to generate the mature form of the protein.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "protein autoprocessing"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.988 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.902 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.780 | ||
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.699 | ||
| CAPNS1 | calpain, small subunit 1 | 0.579 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.532 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.404 | ||
| PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.369 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.245 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.209 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.158 | ||
| PLAT | plasminogen activator, tissue | 0.154 | Human | |
| CARD16 | caspase recruitment domain family, member 16 | 0.128 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.117 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.116 | ||
| PLAU | plasminogen activator, urokinase | 0.112 | Human | |
| IFI16 | interferon, gamma-inducible protein 16 | 0.108 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.106 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.099 | ||
| TADA3 | transcriptional adaptor 3 | 0.079 | ||
| APLF | aprataxin and PNKP like factor | 0.060 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.058 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.058 | ||
| SP100 | SP100 nuclear antigen | 0.041 | ||
| APTX | aprataxin | 0.041 | ||
| LDLR | low density lipoprotein receptor | 0.040 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.040 | ||
| IL18 | interleukin 18 (interferon-gamma-inducing factor) | 0.039 | ||
| MTHFD1L | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like | 0.036 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.034 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.034 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.033 | ||
| RAI1 | retinoic acid induced 1 | 0.032 | ||
| HDAC1 | histone deacetylase 1 | 0.032 | ||
| NMT1 | N-myristoyltransferase 1 | 0.031 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.029 | ||
| TLR1 | toll-like receptor 1 | 0.028 | ||
| HNRNPL | heterogeneous nuclear ribonucleoprotein L | 0.027 | ||
| KNG1 | kininogen 1 | 0.027 | ||
| UNG | uracil-DNA glycosylase | 0.026 | ||
| VTN | vitronectin | 0.025 | ||
| KYNU | kynureninase | 0.025 | ||
| ORM1 | orosomucoid 1 | 0.024 | ||
| BCL2A1 | BCL2-related protein A1 | 0.024 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.023 | ||
| AMT | aminomethyltransferase | 0.022 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.022 | ||
| PYCARD | PYD and CARD domain containing | 0.022 | ||
| CAST | calpastatin | 0.021 | ||
| ANXA2 | annexin A2 | 0.021 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.020 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.020 | ||
| HDGF | hepatoma-derived growth factor | 0.020 | ||
| WFDC2 | WAP four-disulfide core domain 2 | 0.019 | ||
| PIAS2 | protein inhibitor of activated STAT, 2 | 0.019 | ||
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.019 | ||
| IL1A | interleukin 1, alpha | 0.018 | ||
| CLEC2B | C-type lectin domain family 2, member B | 0.018 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.018 | ||
| MUC4 | mucin 4, cell surface associated | 0.018 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.018 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.018 | ||
| CARD6 | caspase recruitment domain family, member 6 | 0.017 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.017 | ||
| GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.017 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.017 | ||
| TRIM22 | tripartite motif containing 22 | 0.017 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.017 | ||
| LIG3 | ligase III, DNA, ATP-dependent | 0.017 | ||
| SQRDL | sulfide quinone reductase-like (yeast) | 0.016 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.016 | ||
| GCGR | glucagon receptor | 0.016 | ||
| TFR2 | transferrin receptor 2 | 0.016 | ||
| TMPRSS11D | transmembrane protease, serine 11D | 0.015 | ||
| PIGR | polymeric immunoglobulin receptor | 0.015 | ||
| EMP1 | epithelial membrane protein 1 | 0.015 | ||
| IL1B | interleukin 1, beta | 0.015 | ||
| C4BPB | complement component 4 binding protein, beta | 0.015 | ||
| CHD1L | chromodomain helicase DNA binding protein 1-like | 0.015 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.015 | ||
| MLKL | mixed lineage kinase domain-like | 0.014 | ||
| CRP | C-reactive protein, pentraxin-related | 0.014 | ||
| GJB1 | gap junction protein, beta 1, 32kDa | 0.014 | ||
| SAMD9L | sterile alpha motif domain containing 9-like | 0.014 | ||
| USF1 | upstream transcription factor 1 | 0.014 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.014 | ||
| PLG | plasminogen | 0.013 | Human | |
| CTSS | cathepsin S | 0.013 | ||
| CTSC | cathepsin C | 0.013 | ||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.013 | ||
| PRR15L | proline rich 15-like | 0.013 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.013 | ||
| TNS1 | tensin 1 | 0.013 | ||
| HABP2 | hyaluronan binding protein 2 | 0.013 | Human | |
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.012 | ||
| PROZ | protein Z, vitamin K-dependent plasma glycoprotein | 0.012 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.012 | ||
| VIL1 | villin 1 | 0.012 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.012 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.012 | ||
| GLP1R | glucagon-like peptide 1 receptor | 0.012 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.012 | ||
| SAA4 | serum amyloid A4, constitutive | 0.012 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.012 | ||
| AXL | AXL receptor tyrosine kinase | 0.012 | ||
| CAPN2 | calpain 2, (m/II) large subunit | 0.012 | Rat | |
| RAB17 | RAB17, member RAS oncogene family | 0.012 | ||
| TFF3 | trefoil factor 3 (intestinal) | 0.012 | ||
| XDH | xanthine dehydrogenase | 0.012 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.012 | ||
| DAXX | death-domain associated protein | 0.012 | ||
| SUMO4 | SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae) | 0.011 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.011 | ||
| IL15 | interleukin 15 | 0.011 | ||
| APOL6 | apolipoprotein L, 6 | 0.011 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.011 | ||
| MCPH1 | microcephalin 1 | 0.011 | ||
| SORD | sorbitol dehydrogenase | 0.011 | ||
| EVI2A | ecotropic viral integration site 2A | 0.011 | ||
| METTL13 | methyltransferase like 13 | 0.011 | ||
| FGB | fibrinogen beta chain | 0.011 | ||
| SMAD7 | SMAD family member 7 | 0.011 | ||
| GLRX | glutaredoxin (thioltransferase) | 0.011 | ||
| APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 0.011 | ||
| GLIPR1 | GLI pathogenesis-related 1 | 0.011 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.011 | ||
| NLRP2 | NLR family, pyrin domain containing 2 | 0.011 | ||
| TRIM38 | tripartite motif containing 38 | 0.011 | ||
| S100A10 | S100 calcium binding protein A10 | 0.011 | ||
| LY96 | lymphocyte antigen 96 | 0.011 | ||
| TM4SF4 | transmembrane 4 L six family member 4 | 0.010 | ||
| MYOF | myoferlin | 0.010 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.010 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.010 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.010 | ||
| CDHR2 | cadherin-related family member 2 | 0.010 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.010 | ||
| HPN | hepsin | 0.010 | Human | |
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.010 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.010 | ||
| PDGFC | platelet derived growth factor C | 0.010 | ||
| OSMR | oncostatin M receptor | 0.010 | ||
| SLC25A15 | solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 | 0.010 | ||
| APOL3 | apolipoprotein L, 3 | 0.010 | ||
| PLAC8 | placenta-specific 8 | 0.010 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.010 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.010 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.010 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.010 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.010 | ||
| C8G | complement component 8, gamma polypeptide | 0.010 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.010 |